PLAT and Stroke: Following the European Cooperative Acute Stroke Study [ECASS] III trial, all patients underwent IVT (intravenous thrombolysis) with t-PA (tissue plasminogen activator, alteplase) within 4.5 h of stroke onset at a maximum dose of 0.9 mg/kg.